Clinical audit: baseline Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) assessment of psoriasis patients

Authors

  • Mansoor Dilnawaz
  • Sakina Sadiq
  • Zafar Iqbal Shaikh
  • Humera Aziz
  • Saima Ali Khan
  • Beenish Jawad

Keywords:

Clinical audit, PASI, DLQI

Abstract

Objective To assess the combined effect of PASI and DLQI on the overall care and treatment plan. Patients and methods 30 patients of psoriasis were included from the dermatology ward and the out-patients. The method of data collection was prospective. The basis of proposal was our local guidelines. The audit type was Process. The standard was “100% patients with psoriasis should have their baseline PASI and Dermatology DLQI ”. Results The result showed 100% compliance with our local guidelines in the analyzed cases. Conclusion PASI and DLQI combined can thus be quite helpful and can have an impact on the overall care and the treatment plan. 

References

Johnson MA, Armstrong AW. Clinical and histologic diagnostic guidelines for psoriasis: a critical review. Clin Rev Allergy Immunol. 2013;44:166-72.

Jobling R. A patient's journey: Psoriasis. Br Med J. 2007;334 (7600):953-4.

Learn: About psoriasis". National Psoriasis Foundation.

Committee for Medicinal Products for Human Use (CHMP) (18 November 2004). "Guideline on Clinical Investigation of Medicinal Products indicated for the treatment of Psoriasis"

http://www.psoriasis.org/learn_statistics Statistic from Psoriasis.org.

Sampogna F, Chren MM, Melchi CF et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006;154:325-31.

Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol. 2007;25:555-62.

Magin P, Adams J, Heading G et al. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study. Scand J Caring Sci. 2008;22:430-6.

Finlay AY, Khan G: Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.

Finlay AY, Khan GK. Dermatology Life Quality Index. April 1992 www.dermatology.org.uk.

Finlay AY. Current severe psoriasis and the Rule of Tens. Br J Dermatol. 2005;152:861-7.

Smith CH, Anstey AV, Barker JNWN et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol. 2005;153:486-97.

Downloads

Published

2016-12-16

How to Cite

1.
Dilnawaz M, Sadiq S, Shaikh ZI, Aziz H, Khan SA, Jawad B. Clinical audit: baseline Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) assessment of psoriasis patients. J Pak Assoc Dermatol [Internet]. 2016Dec.16 [cited 2024Oct.10];23(4):407-11. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/288

Issue

Section

Original Articles

Most read articles by the same author(s)

1 2 > >>